User discusses a promising topical Procyanidin B2 treatment for hair loss. Users share mixed experiences and mention effective treatments like finasteride, minoxidil, and LLLT.
The conversation is about a page stealing personal photos from a subreddit and selling a questionable oil as a hair loss treatment. Users are frustrated and discussing the theft of their images and ineffective moderation.
A user experienced hair growth on their neck after taking saw palmetto, green tea, horsetail, and biotin. They are curious if this is a good sign and why it happened.
The user experienced negative side effects from saw palmetto, including low libido and energy, and found some improvement after using Maca and Acetyl L-Carnitine. They emphasize lifestyle changes and positivity for recovery, while expressing caution about saw palmetto's side effects.
The conversation is about the release timeline for clinical trial results and the availability of Breezula, a hair loss treatment. The user is not comfortable buying it as a research drug from China.
The post and conversation are about a user's progress with microneedling and minoxidil for hair loss. The user is happy with the progress and plans to continue with the treatment, without using finasteride.
The user plans to maintain and improve hair health using finasteride, a balanced diet, exercise, and regular hair care, while avoiding minoxidil. They intend to share weekly updates on their progress.
Pelage Pharmaceuticals announced positive Phase 2a trial results for PP405 in hair loss therapy. The conversation discusses the delay in publishing full results and the need for further trials and approvals.
The conversation is about using finasteride, biotin, and Nizoral shampoo for hair regrowth, with recommendations to add minoxidil for better results. Users suggest that minoxidil is synergistic with finasteride and may enhance hair regrowth, while some also mention microneedling as a beneficial addition.
A new hair loss treatment, pp405, may regrow hair better than finasteride and minoxidil, with potential availability by 2028. However, there is skepticism about its effectiveness and commercialization timeline.
The conversation discusses hair loss treatments, specifically Setipiprant, finasteride, and bimatoprost. Setipiprant is suggested for maintenance, while bimatoprost is for regrowth, and combining them with dermarolling is recommended for better results.
The conversation is about a user sharing their progress with hair loss treatment using 2.5 mg oral finasteride and a 5% minoxidil spray, encouraging others to stay consistent. The user noticed results in mid-August and has not experienced side effects, despite the high dosage of finasteride.
The user experienced side effects from ecklonia cava similar to those reported with finasteride, including depression, brain fog, anxiety, and testicular pain. Despite these issues, the user is still considering using topical finasteride in the future.
Pelage Pharmaceuticals raised $120M for their hair loss treatment, PP405, showing strong investor confidence despite limited data. There is skepticism about its efficacy and long-term effects compared to treatments like GT20029.
There is no new information on pp405, with data collection expected to finish by the end of 2025. Users are discussing the timeline for data analysis and completion of Pelage Pharmaceuticals' phase 2 study.
The user reported noticeable hair regrowth after one month using biotin, zinc, RU58841, finasteride, minoxidil, micro-needling, and oils like rosemary, castor, and argan. They experienced no side effects from oral minoxidil and finasteride, and they apply topical minoxidil twice daily.
A user is concerned about hair shedding despite noticeable regrowth after 7 months of using finasteride. The dermatologist confirmed positive results, but the user remains skeptical and confused.
User TH1RT33N_DR34M shares that MinoxidilMax plans to make topical Procyanidin B2 within a month. Users discuss the legitimacy of the product, quality control, and potential results from using it for hair loss.
Finasteride can affect hormone levels within two weeks, and a break of several weeks is recommended for baseline results. Monitoring E2 and testosterone is suggested to assess the risk of gynecomastia.
The post discusses various hair loss treatments including minoxidil, finasteride, microneedling, vitamins, lifestyle changes, and reducing prolactin levels. The user reports positive results after 4 months of treatment, including increased hair growth.
The user shared progress on hair loss treatment between September and November using oral finasteride, topical minoxidil, dermarolling, a LaserComb, caffeine shampoo, Nizoral, scalp massages, and both oral and topical biotin. The conversation discusses the effectiveness of these treatments.
Stemoxydine is highly recommended for hair loss, preferred over Minoxidil due to fewer side effects and dependency. The user also uses finasteride, Pur'ador shampoo, and suggests cold showers and spicy food as part of their routine.
User tries dermapen for hair loss and plans to use non-mainstream topicals like c60, ghk-cu, and ptd-dbm with valproic acid. They also use a head massager and modified LLLT belt for additional treatment.
The conversation is about someone planning to start finasteride for hair loss and wanting to interpret pre-treatment blood panels to assess the risk of side effects like gynecomastia. They list various tests to measure hormone levels and other health indicators.
Breezula (clascoterone) Phase 3 hair loss trial results are delayed, with no official updates yet. The acne version is approved, but hair loss results are still pending.
The post and conversation discuss Verteporfin's potential as a hair loss treatment. It's shown promise in regrowing hair after transplants and might be effective with microneedling.
A 51-year-old woman switched from Minoxidil to Maneup, a copper peptide treatment, experiencing initial hair loss but later regrowth with different hair texture. Users debated Maneup's effectiveness, with some considering it alongside finasteride.
Dr. Bloxham's trial is testing verteporfin on hair transplant patients to see if it can improve hair regrowth in treated areas. People are discussing the potential for follicle regeneration, expected results timeline, and concerns about side effects like cancer.